Posted by June 10th, 2010
Young patients with stage II or III colon cancer get equal benefit from chemotherapy as older patients, and they have similar side effects.
Five years after treatment, 67 percent of patients under the age of fifty hadn’t had their cancer spread beyond the colon (recurrence-free interval), the same percentage that applied to patients who were fifty or over.
Overall survival and disease-free survival were somewhat better for young patients because they had fewer other reasons for dying. Overall and disease-free survival reflect patients who are alive five years after beginning treatment. Neither includes people who have died from any cause, including their cancer. Read the rest of this entry »